Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous immunoglobulin treatment in patients with multifocal motor neuropathy
2005-000934-19Phase 2Completed
- Sponsor
- Aarhus University Hospital Neurological Department
- Start
- Apr 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of subcuvia and ALYGLO in multifocal motor neuropathy (MMN) (2 arms), sponsored by Aarhus University Hospital Neurological Department. Started Apr 2005; status: completed.
02
Drugs
subcuviaALYGLO
03
Conditions
multifocal motor neuropathy (MMN)
Beyond the preview
Go deeper on 2005-000934-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000934-19.